Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evaluate Pharma
Pharma
Lilly, Novo will be pharma sales leaders by 2030, Evaluate says
Fueled by sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030, Evaluate projects.
Kevin Dunleavy
Jun 23, 2025 9:52am
Top 10 most anticipated drug launches of 2025
Jan 27, 2025 3:00am
Orphan drug market to reach $270B by 2028: Evaluate
Apr 24, 2024 12:01am
For CDMOs, employment and funding hitches persist after pandemic
Jan 8, 2024 10:52am
Roche and Keytruda will lead company, drug sales in 2028: report
Aug 21, 2023 8:50am
AbbVie predicted to be top pharma company by sales in 2028
Jun 1, 2022 6:33am
